About the Canadian Cannabis and Health Dashboard

Canada legalized non-medical cannabis for adult use in October 2018. The goal of this dashboard is to provide contemporary data on changes in key cannabis market and health indicators over time. Market indicators include cannabis sales, access to cannabis retail stores and key regulation changes. Health outcomes will include emergency department (ED) visits and hospitalizations caused by cannabis along with cannabis-involvement in key outcomes (e.g. motor vehicle collisions, during pregnancy).

Market indicators comes from publicly available sales and demographic data from Statistics Canada and from a CIHR funded project tracking the location and operating status of every cannabis store in Canada over time. Health outcomes will be obtained from administrative data capturing all health care visits in Ontario, and all hospitalizations in Canada.

Daniel Myran, MD, MPH, is the Principal Investigator for the Canadian Health Dashboard Project. He is a family medicine and public health and preventive medicine physician. He is an assistant professor with the Department of Family Medicine at the University of Ottawa where he holds a Canada Research Chair in Social Accountability. He is also an investigator at the Bruyère Research Institute and an Adjunct Scientist with ICES. His research focuses on using natural experiments combined with linked health administrative data to better understand the burden of substance use and mental health in Canada and the impacts of public policy. He is currently leading several projects that aim to better understand the health impacts of alcohol and cannabis policy with a focus on their influence on disparities in vulnerable communities.